BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 84 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,446 | -65.8% | 16,777 | -10.0% | 0.00% | – |
| Q2 2023 | $124,196 | -52.6% | 18,648 | +32.7% | 0.00% | – |
| Q1 2023 | $262,210 | -23.4% | 14,052 | -11.8% | 0.00% | – |
| Q4 2022 | $342,155 | +141.0% | 15,929 | +32.8% | 0.00% | – |
| Q3 2022 | $142,000 | -12.9% | 11,991 | -2.6% | 0.00% | – |
| Q2 2022 | $163,000 | -28.8% | 12,315 | +12.6% | 0.00% | – |
| Q1 2022 | $229,000 | -7.3% | 10,936 | +34.6% | 0.00% | – |
| Q3 2021 | $247,000 | +17.1% | 8,127 | +12.1% | 0.00% | – |
| Q2 2021 | $211,000 | -69.9% | 7,253 | -55.1% | 0.00% | -100.0% |
| Q3 2020 | $700,000 | – | 16,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |